B Zinman, J Gerich, JB Buse, A Lewin, S … - Diabetes Care, 2009 - Am Diabetes Assoc RESULTS Mean A1C values decreased significantly more in the liraglutide groups
versus placebo (mean ± SE −1.5 ± 0.1% for both 1.2 and 1.8 mg liraglutide
and −0.5 ± 0.1% for placebo). Fasting plasma glucose decreased by 40, ... Cited by 4 - Related articles - All 2 versions
J Rosenstock, J Reusch, M Bush, F Yang, M … - Diabetes Care, 2009 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS In this randomized multicenter double-blind
parallel-group study, 356 type 2 diabetic subjects with similar mean baseline
characteristics (age 54 years, diabetes duration 4.9 years, BMI 32.1 kg/m 2 ... Cited by 2 - Related articles - All 3 versions
JB McGill - Postgraduate medicine, 2009 - ncbi.nlm.nih.gov Glucose homeostasis is governed by a complex interplay of hormonal signaling and
modulation. Insulin, glucagon, amylin, the incretin hormones glucose-dependent
insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), and ... Cited by 2 - Related articles
- ►bentham.org [PDF] SA Doggrell - Reviews on Recent Clinical Trials, 2007 - ingentaconnect.com Abstract: The obesity epidemic in the developed and developing world is being
followed by an epidemic of type 2 diabetes. In type 2 diabetes, subjects cannot
manage glucose properly because they do not produce enough insulin, and the ... Cited by 1 - Related articles - BL Direct - All 5 versions
JB Buse, J Rosenstock, G Sesti, WE Schmidt, … - The Lancet, 2009 - Elsevier Mean baseline HbA 1c for the study population was 8·2%. Liraglutide reduced
mean HbA 1c significantly more than did exenatide (−1·12% [SE 0·08] vs
−0·79% [0·08]; estimated treatment difference −0·33; 95% CI −0·47 ... Cited by 15 - Related articles - All 25 versions
- ►nih.gov D Russell-Jones, A Vaag, O Schmitz, BK Sethi, … - Diabetologia, 2009 - Springer Abstract Aims/hypothesis The aim of the study was to compare the efficacy and
safety of liraglutide in type 2 diabetes mellitus vs placebo and insulin
glargine (A21Gly,B31Arg,B32Arg human insulin), all in combination with ... Cited by 6 - Related articles - All 3 versions
[CITATION] A study of two glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes …
